Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.


Cytogenetic analysis has an essential role in diagnosis, classification, and prognosis of myelodysplastic syndromes (MDS). Some cytogenetic abnormalities are sufficiently characteristic of MDS to be considered MDS defining in the appropriate clinical context. MDS with isolated del(5q) is the only molecularly defined MDS subtype. The genes responsible for… (More)


Cite this paper

@article{Wall2017RecurrentCA, title={Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.}, author={Meaghan Wall}, journal={Methods in molecular biology}, year={2017}, volume={1541}, pages={209-222} }